Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: tktrimbath who wrote (368)	9/17/2002 12:34:19 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 557

Little monetary value assigned for good work: An 'A' for effort but Wall street is mean and nasty. So...Tgen is valued at less than half what Genovo cost now, right? Could be worse, Valentis shares changing shares around 30 cents today, putting VLTS marketcap around $11M--surely GeneSwitch alone is worth more than that. And so it goes... A bunch of Tgen shares will probably change hands at 50 cents, then a buyer is found for a buck, somebody at the end of the game always gets a double. Wow, a post to less-than-cash board on SGMO-I'd not checked the quote on that one for awhile, what a wipe out!